Cargando…

Electronic Monitoring Of Mom's Schedule (eMOMS™): Protocol for a feasibility randomized controlled trial to improve postpartum weight, blood sugars, and breastfeeding among high BMI women

BACKGROUND: Overweight and obesity are major risk factors for gestational diabetes among U.S. women. Evidence suggests that longer duration of breastfeeding among women with a history of gestational diabetes is associated with lower incidence of developing type 2 diabetes after pregnancy. Women may...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobson, Lisette T., Collins, Tracie C., Lucas, Meredith, Zackula, Rosey, Okut, Hayrettin, Nazir, Niaman, Robbins, David, Stern, Judy E., Wolfe, Michael, Grainger, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183152/
https://www.ncbi.nlm.nih.gov/pubmed/32346648
http://dx.doi.org/10.1016/j.conctc.2020.100565
_version_ 1783526375430291456
author Jacobson, Lisette T.
Collins, Tracie C.
Lucas, Meredith
Zackula, Rosey
Okut, Hayrettin
Nazir, Niaman
Robbins, David
Stern, Judy E.
Wolfe, Michael
Grainger, David A.
author_facet Jacobson, Lisette T.
Collins, Tracie C.
Lucas, Meredith
Zackula, Rosey
Okut, Hayrettin
Nazir, Niaman
Robbins, David
Stern, Judy E.
Wolfe, Michael
Grainger, David A.
author_sort Jacobson, Lisette T.
collection PubMed
description BACKGROUND: Overweight and obesity are major risk factors for gestational diabetes among U.S. women. Evidence suggests that longer duration of breastfeeding among women with a history of gestational diabetes is associated with lower incidence of developing type 2 diabetes after pregnancy. Women may potentially benefit from a lifestyle change program that includes breastfeeding education and support. PURPOSE: To describe the design and justification of a combined breastfeeding, national Diabetes Prevention Program (DPP)-based feasibility randomized controlled trial, the electronic Monitoring Of Mom's Schedule (eMOMS(TM)) study. eMOMS(TM) compares the feasibility and efficacy of three interventions on six-month postpartum weight loss among women with a BMI ≥25. METHODS: The intervention is delivered via Facebook and includes three groups: DPP and breastfeeding (eMOMS1); DPP only (eMOMS2); and Usual Care (eMOMS3). Recruitment is ongoing at two clinical sites (rural and urban). A total of 72 women, 24 per group, will be randomly assigned to one of the three groups. It is anticipated that women in eMOMS1 will have greater weight loss and increased length of breastfeeding at three and six months postpartum compared to women in eMOMS2 and eMOMS3. Additional data will be collected on metabolic markers, anthropometrics, physical activity, nutrition, breastfeeding, and depression. Program cost will be compared to that of traditionally scheduled group meetings. Expected study completion date: October 2021. CONCLUSIONS: This study has the potential to define a high impact, cost effective intervention that can improve public health by reducing negative health outcomes associated with gestational diabetes among an at-risk population.
format Online
Article
Text
id pubmed-7183152
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-71831522020-04-28 Electronic Monitoring Of Mom's Schedule (eMOMS™): Protocol for a feasibility randomized controlled trial to improve postpartum weight, blood sugars, and breastfeeding among high BMI women Jacobson, Lisette T. Collins, Tracie C. Lucas, Meredith Zackula, Rosey Okut, Hayrettin Nazir, Niaman Robbins, David Stern, Judy E. Wolfe, Michael Grainger, David A. Contemp Clin Trials Commun Article BACKGROUND: Overweight and obesity are major risk factors for gestational diabetes among U.S. women. Evidence suggests that longer duration of breastfeeding among women with a history of gestational diabetes is associated with lower incidence of developing type 2 diabetes after pregnancy. Women may potentially benefit from a lifestyle change program that includes breastfeeding education and support. PURPOSE: To describe the design and justification of a combined breastfeeding, national Diabetes Prevention Program (DPP)-based feasibility randomized controlled trial, the electronic Monitoring Of Mom's Schedule (eMOMS(TM)) study. eMOMS(TM) compares the feasibility and efficacy of three interventions on six-month postpartum weight loss among women with a BMI ≥25. METHODS: The intervention is delivered via Facebook and includes three groups: DPP and breastfeeding (eMOMS1); DPP only (eMOMS2); and Usual Care (eMOMS3). Recruitment is ongoing at two clinical sites (rural and urban). A total of 72 women, 24 per group, will be randomly assigned to one of the three groups. It is anticipated that women in eMOMS1 will have greater weight loss and increased length of breastfeeding at three and six months postpartum compared to women in eMOMS2 and eMOMS3. Additional data will be collected on metabolic markers, anthropometrics, physical activity, nutrition, breastfeeding, and depression. Program cost will be compared to that of traditionally scheduled group meetings. Expected study completion date: October 2021. CONCLUSIONS: This study has the potential to define a high impact, cost effective intervention that can improve public health by reducing negative health outcomes associated with gestational diabetes among an at-risk population. Elsevier 2020-04-08 /pmc/articles/PMC7183152/ /pubmed/32346648 http://dx.doi.org/10.1016/j.conctc.2020.100565 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Jacobson, Lisette T.
Collins, Tracie C.
Lucas, Meredith
Zackula, Rosey
Okut, Hayrettin
Nazir, Niaman
Robbins, David
Stern, Judy E.
Wolfe, Michael
Grainger, David A.
Electronic Monitoring Of Mom's Schedule (eMOMS™): Protocol for a feasibility randomized controlled trial to improve postpartum weight, blood sugars, and breastfeeding among high BMI women
title Electronic Monitoring Of Mom's Schedule (eMOMS™): Protocol for a feasibility randomized controlled trial to improve postpartum weight, blood sugars, and breastfeeding among high BMI women
title_full Electronic Monitoring Of Mom's Schedule (eMOMS™): Protocol for a feasibility randomized controlled trial to improve postpartum weight, blood sugars, and breastfeeding among high BMI women
title_fullStr Electronic Monitoring Of Mom's Schedule (eMOMS™): Protocol for a feasibility randomized controlled trial to improve postpartum weight, blood sugars, and breastfeeding among high BMI women
title_full_unstemmed Electronic Monitoring Of Mom's Schedule (eMOMS™): Protocol for a feasibility randomized controlled trial to improve postpartum weight, blood sugars, and breastfeeding among high BMI women
title_short Electronic Monitoring Of Mom's Schedule (eMOMS™): Protocol for a feasibility randomized controlled trial to improve postpartum weight, blood sugars, and breastfeeding among high BMI women
title_sort electronic monitoring of mom's schedule (emoms™): protocol for a feasibility randomized controlled trial to improve postpartum weight, blood sugars, and breastfeeding among high bmi women
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183152/
https://www.ncbi.nlm.nih.gov/pubmed/32346648
http://dx.doi.org/10.1016/j.conctc.2020.100565
work_keys_str_mv AT jacobsonlisettet electronicmonitoringofmomsscheduleemomsprotocolforafeasibilityrandomizedcontrolledtrialtoimprovepostpartumweightbloodsugarsandbreastfeedingamonghighbmiwomen
AT collinstraciec electronicmonitoringofmomsscheduleemomsprotocolforafeasibilityrandomizedcontrolledtrialtoimprovepostpartumweightbloodsugarsandbreastfeedingamonghighbmiwomen
AT lucasmeredith electronicmonitoringofmomsscheduleemomsprotocolforafeasibilityrandomizedcontrolledtrialtoimprovepostpartumweightbloodsugarsandbreastfeedingamonghighbmiwomen
AT zackularosey electronicmonitoringofmomsscheduleemomsprotocolforafeasibilityrandomizedcontrolledtrialtoimprovepostpartumweightbloodsugarsandbreastfeedingamonghighbmiwomen
AT okuthayrettin electronicmonitoringofmomsscheduleemomsprotocolforafeasibilityrandomizedcontrolledtrialtoimprovepostpartumweightbloodsugarsandbreastfeedingamonghighbmiwomen
AT nazirniaman electronicmonitoringofmomsscheduleemomsprotocolforafeasibilityrandomizedcontrolledtrialtoimprovepostpartumweightbloodsugarsandbreastfeedingamonghighbmiwomen
AT robbinsdavid electronicmonitoringofmomsscheduleemomsprotocolforafeasibilityrandomizedcontrolledtrialtoimprovepostpartumweightbloodsugarsandbreastfeedingamonghighbmiwomen
AT sternjudye electronicmonitoringofmomsscheduleemomsprotocolforafeasibilityrandomizedcontrolledtrialtoimprovepostpartumweightbloodsugarsandbreastfeedingamonghighbmiwomen
AT wolfemichael electronicmonitoringofmomsscheduleemomsprotocolforafeasibilityrandomizedcontrolledtrialtoimprovepostpartumweightbloodsugarsandbreastfeedingamonghighbmiwomen
AT graingerdavida electronicmonitoringofmomsscheduleemomsprotocolforafeasibilityrandomizedcontrolledtrialtoimprovepostpartumweightbloodsugarsandbreastfeedingamonghighbmiwomen